Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed‐dose combination treatment for acne vulgaris

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. S5, 2015-06 ,pp. : 8-13

John Wiley & Sons Inc

Access to resources Recommend Favorite

A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: Results from two randomized, parallel-group, placebo-controlled trials

By Cryer Byron L.   Sostek Mark B.   Fort John G.   Svensson Ola   Hwang Clara   Hochberg Marc C.  

Annals of Medicine, Vol. 43, Iss. 8, 2011-12 ,pp. : 594-605

Informa Healthcare

Access to resources Recommend Favorite

Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 599-602

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do tutorials on application method enhance adapalene–benzoyl peroxide combination gel tolerability in the treatment of acne?

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 11, 2015-11 ,pp. : 1058-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double‐blind, active‐controlled, phase 3 trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 590-598

John Wiley & Sons Inc

Access to resources Recommend Favorite